Martin Evans
Generated by GPT-5-miniExpansion Funnel Raw 53 → Dedup 0 → NER 0 → Enqueued 0
| Martin Evans | |
|---|---|
 | |
| Name | Martin Evans |
| Birth date | 1941 |
| Birth place | Stroud |
| Nationality | United Kingdom |
| Fields | Molecular biology, Genetics, Developmental biology |
| Workplaces | University of Cambridge, University of Sussex, Institute of Animal Genetics |
| Alma mater | University of Sussex, University of Edinburgh |
| Known for | Gene targeting, embryonic stem cells, knockout mice |
| Awards | Nobel Prize in Physiology or Medicine, Royal Society |
Martin Evans is a British geneticist and molecular biologist renowned for pioneering work on embryonic stem cells and gene targeting that enabled the creation of knockout mice. His research established foundational methods used across developmental biology, biomedical research, and pharmacology, influencing studies in cancer research, neurobiology, and immunology. He shared major recognition with contemporaries for elucidating mechanisms of precise genetic modification in mammals.
Early life and education
Born in Stroud in 1941, he pursued undergraduate studies at the University of Sussex where he studied biological sciences under tutors engaged with cell biology and biochemistry. He completed doctoral research at the University of Edinburgh in laboratories connected to the Institute of Animal Genetics, working on mammalian embryology and early development. His postgraduate training placed him in contact with laboratories focusing on mouse genetics, embryology, and tissue culture that shaped his methodological approaches.
Research career and contributions
During appointments at the University of Cambridge and the MRC Laboratory of Molecular Biology, he developed techniques to derive pluripotent embryonic stem cell lines from mouse blastocysts, enabling stable culture and germline transmission. Collaborating with researchers in gene targeting and homologous recombination, his work demonstrated that embryonic stem cells could be genetically modified in vitro and introduced into host embryos to produce heritable alterations. These advances were pivotal for producing genetically engineered mouse models used to study oncogenes, tumor suppressor genes, neurological disorders, and immune system function. His methodologies intersected with work at institutions such as the Wellcome Trust, the Howard Hughes Medical Institute, and pharmaceutical research programs that applied knockout technology to model human disease and drug targets.
Evans's papers described culture conditions, selection techniques, and strategies for germline transmission that were adopted broadly across laboratories studying developmental pathways, signal transduction and gene function. The confluence of his stem cell derivation and contemporaneous innovations in recombinant DNA and ES cell manipulation enabled the generation of conditional alleles, reporter lines, and targeted gene disruptions foundational to reverse genetics. His influence extended through collaborations and mentorship with scientists who later contributed to work at the Sanger Institute, Max Planck Society, and numerous university research groups.
Awards and honours
His contributions were recognized by election to the Royal Society and by numerous national and international prizes in biology and medicine. In recognition of the technological and conceptual leap represented by embryonic stem cell derivation and gene targeting, he shared the Nobel Prize in Physiology or Medicine with colleagues who elucidated related mechanisms and applications. He received honorary degrees and fellowships from universities including the University of Cambridge, the University of Edinburgh, and institutions across Europe and North America, and was honored by scientific societies such as the Academia Europaea and national academies of science.
Personal life
He maintained active engagement with academic communities at the University of Cambridge and research councils, contributing to advisory panels on biomedical research and ethics connected to stem cell research and animal models. Outside laboratory work, he participated in public lectures and symposia hosted by organizations such as the Royal Institution and the Royal Society of Biology, discussing implications of genetic engineering and translational research. Colleagues remember him for mentorship of doctoral students and postdoctoral researchers who went on to positions in universities, biotechnology companies, and research institutes.
Selected publications
- Evans, M. et al., papers on derivation of pluripotent embryonic stem cell lines from mouse blastocysts, published in leading journals covering developmental biology and genetics. - Studies coauthored with pioneers in homologous recombination and gene targeting detailing allele modification and germline transmission techniques. - Reviews and perspective articles on the applications of genetically modified mouse models in human disease research, published in outlets read by the biomedical research community. - Methodological works describing culture media, selection markers, and strategies for stable germline contribution of modified lines used by laboratories worldwide.
Category:British geneticists Category:Nobel laureates in Physiology or Medicine